NRSN filings
Corporate insider profile
Alon Ben-Noon Filing Activity
Latest reported as Chief Executive Officer of NeuroSense Therapeutics Ltd. (NRSN).
- Purchase filings
- 1
- Reported companies
- 1
- Net open-market value
- $200,000
- Latest transaction
- Jun 16, 2026
Affiliated corporations
Reported company relationships
Transaction history
